(Q41380354)

30 September 2017

The history of the psychopharmacology of schizophrenia (English)

1 reference

30 September 2017

0 references

H E Lehmann

1

1 reference

PubMed ID

9067064

30 September 2017

T A Ban

series ordinal

2

1 reference

PubMed ID

9067064

30 September 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

Canadian Journal of Psychiatry

30 September 2017

1 reference

30 September 2017

42

1 reference

30 September 2017

2

1 reference

30 September 2017

152-162

1 reference

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

30 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Reserpine (serpasil) in the management of the mentally ill and mentally retarded; preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Dopamine and the pharmacology of schizophrenia: the state of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Midbrain dopamine system electrophysiological functioning: A review and new hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Psychopharmacologic treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

The pharmacoepidemiology of treatment-refractory schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Clozapine-related tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Treatment of the neuroleptic-nonresponsive schizophrenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Psychopharmacologic treatment of negative schizophrenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Dopamine D4 receptors elevated in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

New Antipsychotics: Classification, Efficacy, and Adverse Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

The Mechanism of Action of Novel Antipsychotic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Neurobiology of treatment-resistant schizophrenia: new insights and new models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

Genetic variant near cytosolic phospholipase A2 associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674379704200205

10.1177/070674379704200205

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9067064